Brazil’s ‘Milestone’ Clinical Research Decree Expected To Double Clinical Trials

 
• By Francesca Bruce
  
Brazilian authorities hope that a new decree will help the country climb into the top ten clinical research markets. (Shutterstock)

More from R&D

More from Pink Sheet